Clinical Trials Browser

Phase 2 × Recruiting × apalutamide × Clear all

NCT06832774 2026-03-25

Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients

Phase 2 Recruiting

Prostate Cancer Metastatic Disease

NCT05751941 2026-03-16

Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT04947254 2026-02-19

Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT05534646 2026-02-02

Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT06378866 2025-12-26

DIVINE

Phase 2 Recruiting

Prostatic Neoplasms

NCT06067269 2025-07-15

HEATWAVE

Phase 2 Recruiting

Prostatic Neoplasms

NCT05191680 2025-06-20

TherApeutics in Early ProState Cancer (TAPS02)

Phase 2 Recruiting

Prostatic Neoplasms

NCT06758882 2025-01-06

STAPLE

Phase 2 Recruiting

High Risk Prostate Cancer

NCT04812366 2024-12-16

GUNS

Phase 2 Recruiting

Prostatic Neoplasms

NCT05159245 2024-07-15

FINPROVE

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT05406999 2022-08-16

Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer

Phase 2 Recruiting

Neoadjuvant Therapy